Published in Cancer Weekly, April 17th, 2012
"It may provide rapid and sensitive detection of cancer-related molecular alterations, even in a small percentage of cells. Use of gold nanoparticles derivatized with thiol-modified oligonucleotides (Au-nanoprobes) has been gaining momentum as an alternative to more traditional methodologies. Nevertheless, few reports...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.